FOSTER CITY, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported…
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - September 19, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3)…
Pioneering entrepreneur disrupts the silence with science, community, and commerce—redefining midlife and longevity as power stages of life. DALLAS, Sept.…
The new site solution enables centralized referral management, real-time trial updates and enhanced physician communication to improve patient retention for…
NEW YORK, Sept. 18, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…
MESA, ARIZONA / ACCESS Newswire / September 18, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), a leader in AI-powered…
After treating 50,000+ patients abroad, the Norwegian startup closes $4.5M seed round, opens U.S. headquarters, and launches Acne Care app.…
New in vitro results show Telomir-1 adds KDM5 family inhibition to its previously reported KDM2/KDM6 and DNA methylation activity, potentially…
The Company plans to use the proceeds to accelerate the development of Teverelix, a next generation GnRH Antagonist, as a…
First combination therapy to report 29.5 months of Median Overall Survival (mOS); Standard of care Keytruda® (pembrolizumab) alone (10.8 months)…